| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.896 | 6.380 | 9.659 | 10.766 | 14.795 | 10.957 | 24.687 | 23.766 | 16.062 | 14.273 |
| Total Income - EUR | 8.987 | 6.395 | 9.670 | 10.792 | 14.830 | 10.986 | 24.753 | 23.839 | 16.493 | 14.678 |
| Total Expenses - EUR | 10.560 | 8.251 | 10.190 | 11.564 | 12.739 | 10.948 | 19.343 | 18.188 | 12.916 | 12.476 |
| Gross Profit/Loss - EUR | -1.572 | -1.856 | -520 | -772 | 2.091 | 38 | 5.410 | 5.651 | 3.577 | 2.202 |
| Net Profit/Loss - EUR | -1.842 | -2.029 | -810 | -1.096 | 1.646 | -291 | 4.667 | 4.951 | 2.990 | 1.891 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Ortest Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.871 | 23.467 | 21.800 | 19.448 | 20.429 | 19.278 | 18.103 | 17.410 | 16.610 | 15.774 |
| Current Assets | 17.060 | 15.634 | 15.149 | 14.909 | 14.927 | 14.391 | 17.972 | 20.075 | 23.509 | 27.016 |
| Inventories | 5.077 | 5.092 | 5.045 | 4.907 | 4.745 | 4.531 | 4.255 | 4.267 | 3.884 | 3.655 |
| Receivables | 6.975 | 5.829 | 5.324 | 5.342 | 5.077 | 5.098 | 4.813 | 4.995 | 4.698 | 4.996 |
| Cash | 5.007 | 4.713 | 4.780 | 4.660 | 5.105 | 4.762 | 8.904 | 10.814 | 14.927 | 18.365 |
| Shareholders Funds | -771 | -2.793 | -2.841 | -3.885 | -12 | -304 | 4.370 | 5.699 | 8.672 | 10.514 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 42.701 | 41.894 | 39.790 | 38.242 | 35.369 | 33.972 | 31.705 | 31.786 | 31.446 | 32.275 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ortest Med S.r.l.